What a state sterile compounding licence adds

A second licence stacked on the first

California requires a pharmacy licence for each premises, renewed annually. Sterile compounding is regulated on top of that, in a separate article of the same pharmacy chapter.

The rule is stated as a prohibition rather than a permission. A pharmacy shall not compound sterile drug products unless the pharmacy has obtained a sterile compounding pharmacy licence from the board, and that licence is renewed annually and is not transferable.

The licence is also anchored to the underlying pharmacy in two ways at once. It is issued only to a location that is licensed as a pharmacy, and only to the owner of the pharmacy licensed at that location.

That construction means the sterile licence cannot travel. It is not a credential a company carries between sites or a certification an owner keeps through a sale, because it names both a licensed address and the owner of the licence at that address.

The consequence for anyone reading a pharmacy's credentials is that a general California pharmacy licence is not evidence of sterile compounding authority. They are separate records, and the second one either exists for that address or it does not.

What has to happen before it issues

The inspection requirement is unconditional in both directions. The licence shall not be issued or renewed until the location is inspected by the board and found in compliance with the article and the regulations the board has adopted.

On top of the inspection, the statute lists what the board must do before issuing or renewing, and it is a document review rather than a site visit. The board reviews a current copy of the pharmacy's policies and procedures for sterile compounding.

The board also reviews the pharmacy's completed self-assessment form required by the board's own regulation, which makes the pharmacy's own account of its practice part of the licensing file rather than something held internally.

The board must be provided with copies of all inspection reports conducted of the pharmacy's premises, and any reports from a private accrediting agency, conducted in the prior twelve months and documenting the pharmacy's operations. A private accreditation report is therefore not an alternative to state review in California; it is an input the state reviewer is entitled to see.

Finally, the board receives a list of all sterile medications compounded by the pharmacy since the last licence renewal. The state's file includes what was actually made, not only what the pharmacy is equipped to make.

The out-of-state version, and who pays for the inspection

California applies a parallel licence to pharmacies compounding sterile preparations elsewhere and shipping them in. A nonresident pharmacy shall not compound sterile drug products for shipment into the state without a sterile compounding pharmacy licence issued by the board, renewed annually and not transferable.

It is anchored the same way: issued only to a location licensed as a nonresident pharmacy, and only to the owner of the nonresident pharmacy licensed at that location.

The inspection language is where the out-of-state version differs. The licence shall not be issued or renewed until the location is inspected by the board and found in compliance, and the nonresident pharmacy shall reimburse the board for all actual and necessary costs incurred by the board in conducting an inspection of the pharmacy at least once annually.

That is a state regulator travelling to another state, annually, at the licensee's expense. It is a materially different posture from accepting a home-state inspection report, which is how the same state handles ordinary nonresident pharmacy licensure.

The pre-issuance document review mirrors the in-state list, with one change of scope: the board receives a list of all sterile drug products compounded by the pharmacy within the prior twelve months, rather than since the last renewal.

The carve-out for reconstitution

The statute contains a narrow exception that is easy to over-read, so its two conditions are worth stating exactly.

The reconstitution of a sterile powder does not require a sterile compounding licence if both of the following are met: the sterile powder was obtained from a manufacturer, and the drug is reconstituted for administration to patients by a health care professional licensed to administer drugs by injection under that division of the code.

Both limbs are load-bearing. The powder has to have come from a manufacturer, and the reconstitution has to be for administration by a licensed professional, not for supply.

Nothing in the exception addresses powders that did not come from a manufacturer, or reconstitution done for any purpose other than administration by such a professional. The section simply does not reach those cases, and an exception that does not reach a case is not permission for it.

This is the clearest illustration in the article of why a licence question and a product question are different. Whether an activity needs the licence is settled by the statute; whether a particular preparation was made properly is settled by records the statute does not itself produce.

Outsourcing facilities get their own state licence

The third layer in California is the outsourcing facility, and the statute is explicit that federal registration is not the whole story.

An outsourcing facility that is licensed with the federal Food and Drug Administration and has an address in the state shall also be licensed by the board as an outsourcing facility before doing business within the state. That licence is renewed annually and is not transferable.

The substantive standard is doubled as well. An outsourcing facility shall compound all sterile products and nonsterile products in compliance with regulations issued by the board and with federal current good manufacturing practices applicable to outsourcing facilities.

The pre-issuance review is broader than the pharmacy version. Before inspection the board reviews a current copy of the facility's policies and procedures for sterile and nonsterile compounding; it is provided with copies of all federal and state regulatory agency inspection reports, as well as accreditation reports and certification reports of facilities or equipment, conducted in the prior twelve months; and it receives a list of all sterile and nonsterile drugs compounded as reported to the federal agency in the last twelve months.

That last item is the most quietly significant. The state's file is built partly from what the facility already told the federal agency, which means the two regulators are reading the same production list rather than separate accounts of it.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. California Business and Professions Code section 4127.1, sterile compounding pharmacy licence, pre-issuance review and the reconstitution exception — California Legislative Information, California Legislature, January 2014
2. California Business and Professions Code section 4127.2, sterile compounding licence for nonresident pharmacies shipping into the state, and the annual inspection reimbursed by the licensee — California Legislative Information, California Legislature, January 2014
3. California Business and Professions Code section 4129.1, state licensure of outsourcing facilities in addition to federal registration — California Legislative Information, California Legislature, January 2017
4. California Business and Professions Code section 4110, requiring a board licence for each pharmacy premises and annual renewal — California Legislative Information, California Legislature, January 2022